Remove Containment Remove Contamination Remove Development
article thumbnail

Chemical synthesis: containment challenges for HPAPI handling

Pharmaceutical Technology

These facilities are often multi-use CMO facilities, which combined with the use of HPAPIs, require stringent containment solutions to prevent cross-contamination. Single-use products significantly reduce the time needed for cleaning processes, without the risk of cross-contamination. Chemical synthesis solutions. Free Webinar.

article thumbnail

The rising importance of containment in small molecule drug development

Pharmaceutical Technology

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. Cross-contamination of standard products with highly potent ones is another key concern. Prioritising safety in early-stage development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How API CMOs can improve containment capabilities without facility acquisition

Pharmaceutical Technology

According to GlobalData analysis, specialist small molecule API capabilities such as containment or controlled substances are driving large contract manufacturing organisations (CMOs) to acquire facilities. Flexible containment solutions for potent APIs. Partnering with containment experts.

article thumbnail

Mitigating the risks of cross-contamination during Oral Solid Dose (OSD) manufacturing

Pharmaceutical Technology

Additionally, OSD manufacturing approaches are well developed, with processes that ensure a repeatable distribution of ingredients, uniformity in dissolution, and bioavailability, which verify that the drug product is safe and effective.

article thumbnail

A winning combination: The benefits of micronization and containment in a single installation

Pharmaceutical Technology

This, coupled with small pharma companies being unable to acquire or access containment capabilities in-house, means that the demand for innovative specialized small molecule capabilities remains high. Premium specialized equipment is necessary because high containment facilities call for the separation of the operator from the product.

article thumbnail

IN FOCUS: Northgate Technologies

Pharmaceutical Technology

Such issues are not surprising when one considers that smoke in theatre - caused by the thermal destruction of tissue - can contain pollutants such as benzene, hydrogen cyanide, formaldehyde and bioaerosols. In addition the smoke also causes practical issues in theatre, obscuring the view of medical professionals.

article thumbnail

Choosing a Baby Formula

Pharma Mirror

Families are taking a hard look at how baby formulas’ ingredients impact their children’s health and development. As long as the ingredients are deemed “safe” and contamination-free, there are no specific concrete rules. Infant nutrition, outside of breastfeeding, has become a hot topic recently.